Table 1.
Characteristics of the study population.
| Patients (n = 12) | Healthy Controls (n = 11) | p-Value | |
|---|---|---|---|
| Male:female (N:N) | 8:4 | 7:4 | 0.879 |
| Age (years, mean, SD) | 33.25 (10.50) | 31.82 (13.39) | 0.777 |
| IQ score (mean, SD) | 110.58 (10.73) | 111.30 (8.25) | 0.865 |
| Age of onset EDS (years, mean, SD) | 19.42 (9.15) | - | |
| EDS duration (years, median, IQR) | 10.00 (6.00-25.25) | - | |
| Cataplexy presence | 9/12 | - | |
| Cataplexy and/or hypocretin deficiency (N, %) | 12/12 | - | |
| HLA DQB1*0602 presence (N, %) | 12/12 | - | |
| ESS score (mean, SD) | 10.08 (3.00) | 2.64 (1.96) | <0.001 |
| MSLT: | |||
| Sleep latency (minutes, mean, SD) | 4.62 (3.64) | - | |
| SOREM periods (mean, SD) | 2.58 (1.57) | - |
EDS, excessive daytime sleepiness; HLA, human leukocyte antigen; ESS, Epworth sleepiness scale; MSLT, multiple sleep latency test; SOREM, sleep-onset rapid eye movement.